These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9484801)
41. Activation of the Torpedo nicotinic acetylcholine receptor. The contribution of residues alphaArg55 and gammaGlu93. Kapur A; Davies M; Dryden WF; Dunn SM FEBS J; 2006 Mar; 273(5):960-70. PubMed ID: 16478470 [TBL] [Abstract][Full Text] [Related]
42. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence. Wieczorek Z; Słoń JJ; Siemion IZ Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160 [TBL] [Abstract][Full Text] [Related]
43. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521 [TBL] [Abstract][Full Text] [Related]
44. Amino acid sequence of acylphosphatase from porcine skeletal muscle. Mizuno Y; Yamazaki M; Takasawa T; Kizaki T; Shiokawa H J Biochem; 1985 Apr; 97(4):1135-42. PubMed ID: 2993259 [TBL] [Abstract][Full Text] [Related]
45. The amino acid sequence of ferredoxin II from Chlorobium limicola, a photosynthetic green bacterium. Tanaka M; Haniu M; Yasunobu KT; Evans MC; Rao KK Biochemistry; 1975 May; 14(9):1938-43. PubMed ID: 1125205 [TBL] [Abstract][Full Text] [Related]
46. Expression and renaturation of the N-terminal extracellular domain of torpedo nicotinic acetylcholine receptor alpha-subunit. Schrattenholz A; Pfeiffer S; Pejovic V; Rudolph R; Godovac-Zimmermann J; Maelicke A J Biol Chem; 1998 Dec; 273(49):32393-9. PubMed ID: 9829968 [TBL] [Abstract][Full Text] [Related]
48. Structure-function relationships of curaremimetic neurotoxin loop 2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine receptor. Lentz TL Biochemistry; 1991 Nov; 30(45):10949-57. PubMed ID: 1932020 [TBL] [Abstract][Full Text] [Related]
49. Interaction of protein ligands with receptor fragments. On the residues of curaremimetic toxins that recognize fragments 128-142 and 185-199 of the alpha-subunit of the nicotinic acetylcholine receptor. Fulachier MH; Mourier G; Cotton J; Servent D; Ménez A FEBS Lett; 1994 Feb; 338(3):331-8. PubMed ID: 8307203 [TBL] [Abstract][Full Text] [Related]
50. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors. Weiland GA; Durkin JA; Henley JM; Simasko SM Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113 [TBL] [Abstract][Full Text] [Related]
51. Amino acid sequence and disulfide bridges of an antifungal protein isolated from Aspergillus giganteus. Nakaya K; Omata K; Okahashi I; Nakamura Y; Kolekenbrock H; Ulbrich N Eur J Biochem; 1990 Oct; 193(1):31-8. PubMed ID: 2226447 [TBL] [Abstract][Full Text] [Related]
53. Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites. Le Novère N; Grutter T; Changeux JP Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3210-5. PubMed ID: 11867716 [TBL] [Abstract][Full Text] [Related]
54. Identification of amino acids of the torpedo nicotinic acetylcholine receptor contributing to the binding site for the noncompetitive antagonist [(3)H]tetracaine. Gallagher MJ; Cohen JB Mol Pharmacol; 1999 Aug; 56(2):300-7. PubMed ID: 10419548 [TBL] [Abstract][Full Text] [Related]
55. alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Martinez JS; Olivera BM; Gray WR; Craig AG; Groebe DR; Abramson SN; McIntosh JM Biochemistry; 1995 Nov; 34(44):14519-26. PubMed ID: 7578057 [TBL] [Abstract][Full Text] [Related]
56. Binding sites for alpha-bungarotoxin and the noncompetitive inhibitor phencyclidine on a synthetic peptide comprising residues 172-227 of the alpha-subunit of the nicotinic acetylcholine receptor. Donnelly-Roberts DL; Lentz TL Biochemistry; 1991 Jul; 30(30):7484-91. PubMed ID: 1854749 [TBL] [Abstract][Full Text] [Related]
57. Complete covalent structure of human platelet factor 4. Morgan FJ; Begg GS; Chesterman CN Thromb Haemost; 1980 Feb; 42(5):1652-60. PubMed ID: 6445090 [TBL] [Abstract][Full Text] [Related]
58. Amino acid residues forming the interface of a neuronal nicotinic acetylcholine receptor with kappa-bungarotoxin: a study using single residue substituted peptide analogs. McLane KE; Wu XD; Conti-Tronconi BM Biochem Biophys Res Commun; 1991 Apr; 176(1):11-7. PubMed ID: 2018515 [TBL] [Abstract][Full Text] [Related]
59. Covalent modification of engineered cysteines in the nicotinic acetylcholine receptor agonist-binding domain inhibits receptor activation. McLaughlin JT; Hawrot E; Yellen G Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):765-9. PubMed ID: 7575408 [TBL] [Abstract][Full Text] [Related]
60. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]